Skip to main content

Advertisement

Fig. 3 | Clinical Proteomics

Fig. 3

From: Serum proteomic-based analysis identifying autoantibodies against PRDX2 and PRDX3 as potential diagnostic biomarkers in nasopharyngeal carcinoma

Fig. 3

ROC curve analysis of autoantibodies against PRDX2 and PRDX3 for NPC diagnosis. a ROC curve for serum autoantibodies against PRDX2 and PRDX3 and their combination for patients with NPC versus normal controls. b ROC curve for serum autoantibodies against PRDX2 and PRDX3 and their combination for patients with early NPC versus normal controls. ROC receiver operating characteristic

Back to article page